|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61P 25/06 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3515937 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17785013.8 |
| Date of filing the European patent application | 2017-09-22 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-17 |
| (46) | Date of publication of the claims translation | 2026-02-10 |
| (86) | Number | PCT/IB2017/055777 |
| Date | 2017-09-22 |
| (87) | Number | WO 2018/055574 |
| Date | 2018-03-29 |
| (30) | Number | Date | Country code |
| 201662399180 P | 2016-09-23 | US | |
| 201762558557 P | 2017-09-14 | US |
| (72) |
BIGAL, Marcelo , US
AYCARDI, Ernesto , US
|
| (73) |
Teva Pharmaceuticals International GmbH ,
Schlüsselstrasse 12, 8645 Rapperswil-Jona,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Atsparios migrenos gydymas |
| TREATING REFRACTORY MIGRAINE |